Functional pancreatic beta-cell mass: Involvement in type 2 diabetes and therapeutic intervention

This publication has 53 references indexed in Scilit:

• Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
  Endocrine Reviews, 2008
• Liraglutide, a once‐daily human GLP‐1 analogue, improves pancreatic B‐cell function and arginine‐stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus
  Diabetic Medicine, 2008
• β cell-specific deficiency of the stimulatory G protein α-subunit G _s α leads to reduced β cell mass and insulin-deficient diabetes
  Proceedings of the National Academy of Sciences, 2007
• Endoplasmic Reticulum Stress Signaling in Pancreaticβ-Cells
  Antioxidants and Redox Signaling, 2007
• Efficacy and Safety of Incretin Therapy in Type 2 Diabetes
  JAMA, 2007
• Effects of Once-Weekly Dosing of a Long-Acting Release Formulation of Exenatide on Glucose Control and Body Weight in Subjects With Type 2 Diabetes
  Diabetes Care, 2007
• Molecular regulation of pancreatic β-cell mass development, maintenance, and expansion
  Journal of Molecular Endocrinology, 2007
• Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV
  Critical Reviews in Clinical Laboratory Sciences, 2003
• Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes?
  Trends in Molecular Medicine, 2002
• PSAMMOMYS OBESUS OF THE JERUSALEM COLONY: A MODEL FOR NUTRITIONALLY INDUCED, NON-INSULIN-DEPENDENT DIABETES
  Journal of Basic and Clinical Physiology and Pharmacology, 1993